47 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
board of directors. Among other things, these provisions: establish a classified board of directors such that not all members of the board … activities. Accordingly, we classified this transaction as a “gain on sale of non-financial asset” for the year ended December 31, 2022
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
10 Aug 23
Provides Corporate Updates, and Reports Emerging Data from
6:41am
, which are classified as a liability and are adjusted to fair value each reporting period. Net losses also included $2.1 million of stock-based
424B5
lup2sbomqyen2f3okuwj
8 Dec 22
Prospectus supplement for primary offering
5:47pm
424B5
3g34ld 1f8x
6 Dec 22
Prospectus supplement for primary offering
9:52pm